# Every Member of 23andMe Board Steps Down Amidst Layoffs ## 23andMe Faces Leadership Shakeup The entire board of directors at DNA testing company 23andMe has resigned, including CEO Anne Wojcicki. This follows weeks of layoffs and restructuring at the company. In a statement, 23andMe said that the board had been "working diligently to identify and pursue strategic alternatives for the company." The company did not provide any details about the reasons for the board's resignation or the layoffs. ## Layoffs and Restructuring at 23andMe In recent months, 23andMe has laid off a significant number of employees. In January, the company laid off 100 employees, or about 14% of its workforce. In March, the company laid off an additional 90 employees. The layoffs have been part of a broader restructuring at the company. In January, 23andMe announced that it was cutting back on its research and development spending and focusing on its core business of DNA testing. ## 23andMe's Financial Struggles 23andMe has been facing financial challenges in recent years. The company has never been profitable, and it has been losing money since its launch in 2006. In 2018, the company reported a net loss of $195 million. The company's financial struggles have been compounded by the COVID-19 pandemic. In 2020, the company saw a decline in demand for its DNA testing kits. The company has also been facing competition from other DNA testing companies, such as AncestryDNA and MyHeritage. ## The Future of 23andMe It is unclear what the future holds for 23andMe. The company is facing a number of challenges, including financial struggles, competition, and leadership turnover. However, the company remains a leader in the DNA testing industry. The company has a large database of genetic information and it has developed a number of innovative products and services. It is possible that the company will be able to overcome its challenges and continue to grow in the future.
Comments